Disease activity in ankylosing spondylitis: selection of a core set of variables and a first set in the development of a disease activity score.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  British Journal of Rheumatology

• Publication date

  1996-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/RHEUMATOLOGY/35.9.867PMID 8810670
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Methotrexate in severe ankylosing spondylitis: an open study.

  1995cited by this paper
• A Dutch version of the functional index for ankylosing spondylitis: development and validation in a long-term study.

  1994cited by this paper
• A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index.

  1994cited by this paper
• The natural history of ankylosing spondylitis. Does it burn out?

  1993cited by this paper
• Methods of assessment used in ankylosing spondylitis clinical trials: a review.

  1991cited by this paper
• Outcome assessment in clinical trials of ankylosing spondylitis.

  1991cited by this paper
• Evaluation of a functional index for patients with ankylosing spondylitis.

  1990cited by this paper
• A simple method for measuring lateral flexion of the dorsolumbar spine.

  1990cited by this paper
• Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score.

  1990cited by this paper
• IgA-alpha 1 antitrypsin complexes in ankylosing spondylitis.

  1989cited by this paper
• The natural history of ankylosing spondylitis.

  1988cited by this paper
• IgA containing immune complexes and hematuria in ankylosing spondylitis. A prospective longitudinal study.

  1988cited by this paper
• Evaluation of a functional index and an articular index in ankylosing spondylitis.

  1988cited by this paper
• Immunoglobulin A and C reactive protein levels in ankylosing spondylitis.

  1987cited by this paper
• Correlation of immunoglobulin and C reactive protein levels in ankylosing spondylitis and rheumatoid arthritis.

  1987cited by this paper
• Studies with an enthesis index as a method of clinical assessment in ankylosing spondylitis.

  1987cited by this paper
• Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria.

  1984cited by this paper
• Immunological variables and acute-phase reactants in patients with ankylosing spondylitis (Bechterew's syndrome) and their relatives

  1984cited by this paper
• Acute-phase proteins and serum immunoglobulins in ankylosing spondylitis.

  1983cited by this paper
• Circulating immune complexes in the seronegative spondyloarthropathies.

  1982cited by this paper
• The relationship between disease activity, immunoglobulins and lymphocyte sub-populations in ankylosing spondylitis.

  1982cited by this paper
• Secretory IgA: immune defence pattern in ankylosing spondylitis and klebsiella.

  1981cited by this paper
• A comparison of serum biochemistry in ankylosing spondylitis, seronegative and seropositive rheumatoid arthritis.

  1981cited by this paper
• Problems in the assessment of disease activity in ankylosing spondylitis.

  1981cited by this paper
• C-reactive protein, ESR, and klebsiella in ankylosing spondylitis.

  1980cited by this paper
• A Mixed-longitudinal, interdisciplinary study of growth and development

  1979cited by this paper
• Assessment Of The Flexibility Of The Lumbar Spine: A Pilot Study in Children and Adolescents

  1973cited by this paper
• Haematology and Biochemistry of Ankylosing Spondylitis

  1973cited by this paper
• Serum immunoglobulins in ankylosing spondylitis.

  1973cited by this paper
• Normal range of spinal mobility. An objective clinical study.

  1971cited by this paper
• Coefficient alpha and the internal structure of tests

  1951cited by this paper

• Response to anti-IL17 therapy in inflammatory disease is not strongly impacted by genetic background

  2023cites this paper
• MAY WE USE ENTHESITIS INDICES IN EVALUATING DISEASE ACTIVITY IN PATIENTS WITH ANKYLOSING SPONDYLITIS

  2014cites this paper
• Radiological scoring methods in ankylosing spondylitis: a comparison of the reliability of available methods.

  2010cites this paper
• S PONDYLITIS : A C OMP A RISON O F

  2010cites this paper
• Bone Mineral Density in Patients with Ankylosing Spondylitis

  2008cites this paper
• Bone Mineral Density in Patients with Ankylosing Spondylitis Ankilozan Spondilit Hastalar›nda Kemik Mineral Younluu

  2008cites this paper
• Réponse de phase aiguë, paramètres cliniques et activité inflammatoire dans la spondylarthrite ankylosante

  2007cites this paper
• Acute-phase response, clinical measures and disease activity in ankylosing spondylitis.

  2007cites this paper
• Parameter zur Beurteilung von Krankheitsverlauf und Therapieerfolg

  2005cites this paper
• Assessment of outcome in ankylosing spondylitis: an extended radiographic scoring system

  2004cites this paper
• How to assess musculoskeletal conditions. Assessment of disease activity.

  2003cites this paper
• Assessment of disease activity

  2003cites this paper
• The natural history of ankylosing spondylitis as defined by radiological progression.

  2002cites this paper
• Evaluation of the smallest detectable difference in outcome or process variables in ankylosing spondylitis.

  2002cites this paper
• Aktiver Morbus Bechterew: Symptomatik, Einschränkung der Lebensqualität, Therapiebeurteilung und Therapieerwartung aus Sicht des Patienten

  2001cites this paper
• Development of a disease activity index for the assessment of reactive arthritis (DAREA).

  2000cites this paper
• The Euro-Growth Study: why, who, and how.

  2000cites this paper
• The development and validation of a radiographic grading system for the hip in ankylosing spondylitis: the bath ankylosing spondylitis radiology hip index.

  2000cites this paper
• Outcome variables in ankylosing spondylitis: evaluation of their relevance and discriminant capacity.

  1999cites this paper
• Defining disease activity in ankylosing spondylitis: is a combination of variables (Bath Ankylosing Spondylitis Disease Activity Index) an appropriate instrument?

  1999cites this paper
• Pulmonary function in children affected by juvenile spondyloarthropathy.

  1999cites this paper
• Comparison of the Dougados Functional Index and the Bath Ankylosing Spondylitis Functional Index. A literature review.

  1999cites this paper
• Spondylarthropathy treatment: progress in medical treatment, physical therapy and rehabilitation.

  1998cites this paper
• The Bath Ankylosing Spondylitis Radiology Index (BASRI): a new, validated approach to disease assessment.

  1998cites this paper
• Preliminary core sets for endpoints in ankylosing spondylitis. Assessments in Ankylosing Spondylitis Working Group.

  1997cites this paper